Present address: Director, Liver Program, St Louis Children's Hospital, Washington University, MO, USA.
Acute liver failure in children: A regional experience
Article first published online: 28 APR 2003
Journal of Paediatrics and Child Health
Volume 39, Issue 2, pages 107–110, March 2003
How to Cite
Ee, L., Shepherd, R., Cleghorn, G., Lewindon, P., Fawcett, J., Strong, R. and Lynch, S. (2003), Acute liver failure in children: A regional experience. Journal of Paediatrics and Child Health, 39: 107–110. doi: 10.1046/j.1440-1754.2003.00087.x
- Issue published online: 28 APR 2003
- Article first published online: 28 APR 2003
- Accepted for publication 13 May 2002.
- liver failure;
- liver transplant;
Objective: To review the outcome of acute liver failure (ALF) and the effect of liver transplantation in children in Australia.
Methodology: A retrospective review was conducted of all paediatric patients referred with acute liver failure between 1985 and 2000 to the Queensland Liver Transplant Service, a paediatric liver transplant centre based at the Royal Children's Hospital, Brisbane, that is one of three paediatric transplant centres in Australia.
Results: Twenty-six patients were referred with ALF. Four patients did not require transplantation and recovered with medical therapy while two were excluded because of irreversible neurological changes and died. Of the 20 patients considered for transplant, three refused for social and/or religious reasons, with 17 patients listed for transplantation. One patient recovered spontaneously and one died before receiving a transplant. There were 15 transplants of which 40% (6/15) were < 2 years old. Sixty-seven per cent (10/15) survived > 1 month after transplantation. Forty per cent (6/15) survived more than 6 months after transplant. There were only four long-term survivors after transplant for ALF (27%). Overall, 27% (6/22) of patients referred with ALF survived. Of the 16 patients that died, 44% (7/16) were from neurological causes. Most of these were from cerebral oedema but two patients transplanted for valproate hepatotoxicity died from neurological disease despite good graft function.
Conclusions: Irreversible neurological disease remains a major cause of death in children with ALF. We recommend better patient selection and early referral and transfer to a transplant centre before onset of irreversible neurological disease to optimize outcome of children transplanted for ALF.